NON-SMALL CELL CARCINOMA OF LUNG: TREATMENT OPTIMIZATION
- Authors: Chernykh AV1, Tchernyh AV2
-
Affiliations:
- Lipetsk regional clinical hospital
- Issue: No 12 (2009)
- Pages: 134-143
- Section: Articles
- URL: https://new.vestnik-surgery.com/index.php/2070-9277/article/view/5414
- DOI: https://doi.org/10.18499/2070-9277-2009-0-12-134-143
Cite item
Full Text
Abstract
For years the question is being discussed in printings if the systematic mediastinal lymph dissection has an influence on late fate improvement after a radical surgery in the occasion of lung carcinoma. We have appraised comparatively short-term results of typical and expanded operations. The comparison has been undertaken in groups of patients with identical tumour prevalence (the criteria T, N, M). The analyzable material included 300 patients with lung carcinoma, there were 10 patients with the I (first) stage of disease (7%), 60 patients with the II (second) stage of disease (40%) and 80 patients with the IIIA (third A) stage of disease (53%), in the group of the typical patients there were 45(30%), 43(29%), and 62 persons (41%) respectively. Comparing the general survival rate in the group of expanded operations the survival rate of these patients was higher for sure than in the group after typical operations (P=0,03, log rank test). And the three-year and the five-year general cumulative survival rate after expanded operations made up 70% and 59%, after typical operations - 30% and 9% respectively. The survival rate median was equal to 2100 days (70 months).
About the authors
A V Chernykh
A V Tchernyh
Lipetsk regional clinical hospitalLipetsk regional clinical hospital